RT @montypal: When I approached @ExelixisInc & @genentech, the rationale was straightforward - both #cabozantinib & #atezolizumab had activ…
7,567 followers
2,327 followers
RT @montypal: When I approached @ExelixisInc & @genentech, the rationale was straightforward - both #cabozantinib & #atezolizumab had activ…
33,419 followers
RT @montypal: When I approached @ExelixisInc & @genentech, the rationale was straightforward - both #cabozantinib & #atezolizumab had activ…
164 followers
RT @montypal: When I approached @ExelixisInc & @genentech, the rationale was straightforward - both #cabozantinib & #atezolizumab had activ…